Iodide concentrations in matched maternal serum, cord serum, and amniotic fluid from preterm and term human pregnancies

Reproductive Toxicology

Volumn 25, Issue 1, 2008, Pages 129-132

  Rayburn, William F ^a   Robinson, Alice ^a   Braverman, Lewis E ^b   He, Xue Mei ^b   Pino, Sam ^b   Gargas, Michael L ^c   Kinzell, John H ^d  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Sapphire Group   (United States)

^d ARYSTA LIFESCIENCE CORPORATION   (United States)

Author keywords

Amniotic fluid; Fetal iodide; Maternal iodide; Preterm; Term

Indexed keywords

IODIDE;

ADULT; AMNION FLUID; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORD SERUM; CORRELATION ANALYSIS; FEMALE; HUMAN; MATERNAL SERUM; MEASUREMENT; PREGNANCY COMPLICATION; PREMATURE LABOR; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; TERM BIRTH;

AMNIOTIC FLUID; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; IODIDES; PREGNANCY;

ORYCTOLAGUS CUNICULUS;

EID: 37349086142     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2007.07.004     Document Type: Article

References (21)

1. Nemec, M. A phased-exposure prenatal developmental toxicity study of iodomethane in rabbits: final report. Project No. WIL/418023. Unpublished study prepared by WIL Research Laboratories, Inc., p. 655 MRID#46077001, 2003.
2. Sloter E. Mode of action study for iodomethane-related fetotoxicity in rabbits: final report. Project No. WIL/418032, DUPONT/15855, P0000903. Unpublished study prepared by WIL Research Laboratories, Inc. and E.I. du Pont de Nemours and Company Inc. and Exygen Research, p. 911, MRID No. 46451002. DPR Doc. No. 52875-0086. DPR Record No. 216255, 2005.
3. Morris J.E. The pharmacokinetics of sodium iodide (NaI) in pregnant rabbits. No. 47542. Unpublished study prepared by Battelle, Pacific Northwest Division. 43 p. MRID # 46408808, 2004.
4. Sloter E.D. A combined baseline/inhalation exposure study of iodomethane-related fetotoxicity in rabbits: final report. Project No. WIL/418031, WIL/418031H, WIL/418031I, DUPONT/15244, P0000903. Unpublished study prepared by WIL Research Laboratories, Inc. and E.I. du Pont de Nemours and Company Inc. and Exygen Research, 1631 p., MRID No. 46451001. DPR Doc. No. 52875-0085. DPR Record No. 216254, 2005.
5. Logothetopoulos J., and Scott R.F. Active iodide transport across the placenta of the guinea pig, rabbit and rat. J Physiol 132 (1956) 365-371
6. Crone M., and Waago G. Transfer of radioactive iodide between mother and foetus in the rabbit. Acta Physiol Scand 51 (1961) 84-93
7. Roti E., Gnudi A., and Braverman L.E. The placental transport, synthesis, and metabolism of hormones and drugs which affect thyroid function. Endocr Rev 4 (1983) 131-149
8. Fisher D.A. Fetal thyroid function: diagnosis and management of fetal thyroid disorders. Clin Obstet Gyn 40 (1997) 16-31
9. Roti E., and Vagenakis A.G. Effect of excess iodine: clinical aspects. In: Utiger B. (Ed). Werner and Ingbar's the thyroid, a fundamental and clinical text. 9th ed. (2004), Lippincott Williams and Wilkins, Philadelphia 288-305
10. Liberman C.S., Pino S.C., Fang S.L., Braverman L.E., and Emerson C.H. Circulating iodide concentrations during and after pregnancy. J Clin Endocrinol Metab 83 (1998) 3545-3549
11. Herve F., Moussa F., Raux-Demay M.C., Depasse F., and Udimba S. Blood iodide in cord blood, "masked iodine" and increased neonatal TSH level. Arch Pediatr 4 (1997) 98-99
12. Benotti J., and Benotti N. Protein bound iodine, total iodine and butanol extractable iodine by partial automation. Clin Chem 9 44 (1963) 408-416
13. Mahillon I., Peers W., Bourdoux P., Ermans A.M., and Delange F. Effect of vaginal douching with povidone-iodine during early pregnancy on the iodine supply to mother and fetus. Biol Neonate 56 (1989) 210-217
14. Brown R.S., Huang S.A., and Fisher D.A. The maturation of thyroid function in the perinatal period and during childhood. In: Utiger B. (Ed). Werner and Ingbar's the thyroid, a fundamental and clinical text. 9th ed. (2004), Lippincott Williams and Wilkins, Philadelphia 1013-1028
15. Pauwels E.K.J., Thomson W.H., Blokland J.A.K., Schmidt M.E., Bourguignon M., El-Maghraby T.A., Broerse J.J., and Harding L.K. Aspects of fetal thyroid dose following iodine-131 administration during early stages of pregnancy in patients suffering from benign thyroid disorders. Eur J Nuc Med 26 (1999) 1453-1457
16. Mitchell A.M., Manley S.W., Morris J.C., Powell K.A., Bergert E.R., and Mortimer R.H. Sodium iodide symporter (NIS) gene expression in human placenta. Placenta 22 (2001) 256-258
17. Di Cosmo C., Fannelli G., Tonacchera M., Ferrarini E., Dimida A., Agretti P., De Marco G., Vitti P., Pinchera A., Bevilacquat G., Naccarato A.G., and Viacava P. The sodium iodide symporter expression in placental tissue at different gestational age: an immunohistochemical study. Clin Endocrinol 65 (2006) 544-548
18. Schroder-van der Elst J.P., van der Heide D., Kastelijn J., Rousset B., and Obregon M.J. The expression of the sodium/iodide symporter is up-regulated in the thyroid of fetuses of iodine-deficient rats. Endocrine 142 (2001) 3736-3741
19. Roti E., Fang S.L., Green K., Braverman L.E., and Emerson C.H. Inner ring deiodination of thyroxine and 3,5,3′-triiodothyronine by human fetal membranes. Am J Obstet Gynecol 147 (1983) 788-792
20. Roti E., Fang S.L., Green K., Emerson C.H., and Braverman L.E. Human placenta is an active site of thyroxine and 3,3′,5-triiodothyronine tyrosyl ring deiodination. J Clin Endocrinol Metab 53 (1981) 498-501
21. Eng P.H.K., Cardona G.R., and Fang S.-L. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrine 140 (1999) 3404-3410